These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29782204)

  • 61. Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis.
    Lee YH; Kim JH; Seo YH; Choi SJ; Ji JD; Song GG
    Neurol Sci; 2015 Jan; 36(1):11-20. PubMed ID: 25301263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
    Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
    Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.
    Zaragoza-García O; Guzmán-Guzmán IP; Moreno-Godínez ME; Navarro-Zarza JE; Antonio-Vejar V; Ramírez M; Parra-Rojas I
    Clin Rheumatol; 2021 Feb; 40(2):741-752. PubMed ID: 32556934
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers.
    Albers JW; Garabrant DH; Berent S; Richardson RJ
    J Expo Sci Environ Epidemiol; 2010 Jan; 20(1):79-89. PubMed ID: 19223938
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Mechanisms that protect against homocysteine toxicity].
    Zimny J
    Postepy Biochem; 2008; 54(1):91-8. PubMed ID: 18610586
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Q192R polymorphism of the paraoxonase-1 gene as a risk factor for obesity in Portuguese women.
    Veiga L; Silva-Nunes J; Melão A; Oliveira A; Duarte L; Brito M
    Eur J Endocrinol; 2011 Feb; 164(2):213-8. PubMed ID: 21078685
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192).
    Nakanishi M; Takanami Y; Maruyama T; Murata M; Motohashi Y; Nakano S; Uchida K; Maruyama C; Kyotani S; Tsushima M
    J Atheroscler Thromb; 2003; 10(6):337-42. PubMed ID: 15037822
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies.
    Bae SS; Shahbazian A; Wang J; Golub I; Oganesian B; Dowd T; Vayngortin B; Wang R; Elashoff D; Reddy ST; Charles-Schoeman C
    Rheumatology (Oxford); 2022 May; 61(6):2512-2523. PubMed ID: 34698804
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population.
    Huang Q; Liu YH; Yang QD; Xiao B; Ge L; Zhang N; Xia J; Zhang L; Liu ZJ
    Neurol Res; 2006 Jul; 28(5):549-54. PubMed ID: 16808888
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Paraoxonase 1 (PON1) gene-108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia.
    Bednarska-Makaruk ME; Krzywkowski T; Graban A; Lipczyńska-Łojkowska W; Bochyńska A; Rodo M; Wehr H; Ryglewicz DK
    Folia Neuropathol; 2013; 51(2):111-9. PubMed ID: 23821382
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction.
    Rahman MF; Hashad IM; Abou-Aisha K; Abdel-Maksoud SM; Gad MZ
    Arch Med Sci; 2015 Jun; 11(3):513-20. PubMed ID: 26170843
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Paraoxonase 1 polymorphism and prenatal pesticide exposure associated with adverse cardiovascular risk profiles at school age.
    Andersen HR; Wohlfahrt-Veje C; Dalgård C; Christiansen L; Main KM; Nellemann C; Murata K; Jensen TK; Skakkebæk NE; Grandjean P
    PLoS One; 2012; 7(5):e36830. PubMed ID: 22615820
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease.
    Menezes JF; Carvalho MOS; Rocha LC; Dos Santos FM; Adorno EV; de Souza CC; Santiago RP; da Guarda CC; de Oliveira RM; Figueiredo CVB; Carvalho SP; Yahouédéhou SCMA; Fiuza LM; Adanho CSA; Pitanga TN; Lyra IM; Nascimento VML; Noronha-Dutra AA; Goncalves MS
    Sci Rep; 2023 May; 13(1):7215. PubMed ID: 37137941
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association of Paraoxonase-1 Q192R (rs662) Single Nucleotide Variation with Cardiovascular Risk in Coffee Harvesters of Central Colombia.
    Siller-López F; Garzón-Castaño S; Ramos-Márquez ME; Hernández-Cañaveral I
    J Toxicol; 2017; 2017():6913106. PubMed ID: 29430251
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.
    Bhattacharyya T; Nicholls SJ; Topol EJ; Zhang R; Yang X; Schmitt D; Fu X; Shao M; Brennan DM; Ellis SG; Brennan ML; Allayee H; Lusis AJ; Hazen SL
    JAMA; 2008 Mar; 299(11):1265-76. PubMed ID: 18349088
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans.
    Taravati A; Ardestani SK; Ziaee AA; Ghorbani A; Soroush MR; Faghihzadeh S; Kazemi H; Rezaei A; Hoseini H; Ghazanfari T
    Int Immunopharmacol; 2013 Nov; 17(3):974-9. PubMed ID: 23370296
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q/R phenotypes.
    Mahrooz A; Alizadeh A; Gohari G
    J Neurol Sci; 2014 Mar; 338(1-2):197-202. PubMed ID: 24433930
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Paraoxonase 1 status in the Thai population.
    Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B
    J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.